KISSEI PHARMACEUTICAL CO financial statements, including revenue, expenses, profit, and loss
The total revenue of 4547 for the last quarter is 21.30 B JPY, and it's 0.65% higher compared to the previous quarter. The net income of Q2 24 is 1.14 B JPY.